ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma
Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia
Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO
Phase II Study Finds Dasatinib May Overcome ALL Resistance
Sarcoma Survivors At Risk Of Blood Clots, Study Finds
Risk of Lymphoma Increases with Hepatitis C Virus Infection
Long-Term Results Find Cisplatin Improves Survival
Study Links Ovarian Cancer To Hormone Replacement
Smokers Who Quit Live Longer Than Those Who Spit-Study
FDA Approves New Drug for Advanced Kidney Cancer
FDA Approves New Indication For Anticoagulant Frangmin
NCI-Approved Group, Center Clinical Trials Listed
Trending Stories
- NCI releases names of members of ad hoc working group—filling the void left by BSA
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- ACOG says it will no longer accept federal funding
- NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- AACR Cancer Progress Report makes the case for federal investment in cancer research